A GOP senator says he’s “confident” that, under the Trump administration, lawmakers will help secure alternative treatment options for military veterans—including access to psychedelic medicine, as multiple veterans have personally requested from him after disclosing they’ve travelled abroad for the novel therapy.
And according to a U.S. Department of Veterans Affair (VA) official, a bill the president signed into law this year will streamline research into the therapeutic potential of Schedule I substances like psilocybin and MDMA.
During a Senate Veterans’ Affairs Committee field hearing in Alabama on Friday, Sen. Tommy Tuberville (R-AL) discussed efforts at VA to promote such research, with about a dozen ongoing clinical trials into psychedelics.
“VA Secretary Doug Collins said himself that the VA is continuing to look at new alternative treatments. As a member of this committee, I look forward to working with him and get this done,” Tuberville said, adding that under Collins, U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr. and President Donald Trump, he’s “confident” that the country “will see generational change at the VA for our veterans struggling with their mental health.”
The senator later disclosed that that “veterans come to my office quite often,” and
Read full article on Marijuana Moment
